Study guide

CCRA study guide

Read a lesson, then practice the ideas you want to remember.

Lessons

  1. Potential Fraud, Misconduct and Evidence Pre
  2. Product Accountability and Adherence Calcula
  3. Submissions, Authorisation Status and Trial
  4. Amendment Implementation and Communication
  5. Sponsor, Investigator and Service-Provider R
  6. Close-Out, Archiving and Continuing Obligati
  7. Retention, Destruction and Long-Term Access
  8. Official Blueprint and Study Strategy — Free Study Guide 2026
  9. The CRA Role, Data Integrity and Product Ove
  10. Exploratory, Confirmatory and Therapeutic-Us
  11. Nonclinical Background and Human Pharmacolog
  12. Product Storage, Labelling and Excursion Res
  13. Audit Trails, Electronic Outcomes and Device
  14. EDC Design and Fit-for-Purpose Systems — Free Study Guide 2026
  15. Queries, Coding and Supported Clinical Meani
  16. Device Instructions, Configuration and Train
  17. Estimands and Intercurrent Events — Free Study Guide 2026
  18. Ethical Foundations and the 2024 Declaration
  19. IRB/IEC Composition and Independent Review
  20. Vulnerability, Voluntariness and Compensatio
  21. Consent Documentation, Special Circumstances
  22. Ethics Reporting, Approval Status and Versio
  23. Informed Consent Information and Meaningful
  24. Exam Format, Eligibility and Current Referen
  25. Registration, Fees and Candidate Decisions
  26. Critical Data, Acquisition Tools and Interim
  27. Safety Reconciliation and Dataset Finalisati
  28. Delegation, Qualifications and Task Authorit
  29. Proportionality and Investigator Oversight
  30. The Eleven Current GCP Principles — Free Study Guide 2026
  31. Equipment, Maintenance and Study Supplies
  32. Initiation Training and Readiness Walkthroug
  33. Interim Visit Preparation and Consent Review
  34. Investigator Debrief and Monitoring Reports
  35. Monitoring Eligibility, Safety and Products
  36. Adherence, Discontinuation and Participant C
  37. Conflicts of Interest and Prorated Payments
  38. Safety Communications, Reconciliation and Fo
  39. Clinical Oversight and Immediate-Hazard Chan
  40. Deviation Classification and Resolution
  41. Eligibility Verification and Trial Designs
  42. Endpoint Interpretation and Eligibility Rati
  43. Protocol Elements and Endpoint Hierarchy
  44. KRIs, Acceptable Ranges and Trial-Level Qual
  45. Monitoring Plans, Co-Monitoring and Communic
  46. CAPA Implementation and Effectiveness Verifi
  47. Quality Planning and Risk Management — Free Study Guide 2026
  48. Root Cause Analysis and CAPA Design — Free Study Guide 2026
  49. Bias, Randomisation and Comparator Controls
  50. Reference Safety Information and IB Updates
  51. Unblinding and Investigator Brochure Content
  52. Audits, Inspections and Closure Planning
  53. Essential Records and Site/Sponsor Reconcili
  54. Version History, Resolution Evidence and Non
  55. Ethical Eligibility, Recruitment and Retenti
  56. Privacy, Confidentiality and Appropriate Acc
  57. Monitoring Methods and Source Review — Free Study Guide 2026
  58. Risk Assessment and Centralised Surveillance
  59. Detecting Events, AESIs and Collection Windo
  60. Expedited Reporting and the Sponsor Awarenes
  61. Immediate Site Reporting and Independent Saf
  62. Adverse Event Definitions and Actual Life-Th
  63. Causality, Expectedness and Reference Safety
  64. Seriousness, Severity and Medical Importance
  65. Contracts, Budgets and Operational Feasibili
  66. Specimens, Diagnostic Results and Rater Qual
  67. Recruitment Feasibility and Evidence-Based S
  68. Site Qualification and Investigator Capacity
  69. Site Readiness and Activity-Specific Release
  70. Good Documentation, Completeness and Correct
  71. Source Access, Certified Copies and Context
  72. Source Records and Foundational ALCOA Princi